Multi-omics studies to understand the progression from premalignant states to WM
Simone Ferrero, MD, University of Torino and Hospital "Città della Salute e della Scienza di Torino", Torino, Italy, discusses the potential of multi-omics in understanding the progression from non-tumoral premalignant states to overt Waldenström's macroglobulinemia (WM). He introduces research examining gene mutations, RNA expression, and the role of non-malignant cell mutations in inflammation and disease progression. This interview took place at the 12th International Workshop on Waldenström's Macroglobulinemia (IWWM-12) in Prague, Czech Republic.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.